Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities.

PloS one - 1 Jan 2013

Anderson Per, Carrillo-Gálvez Ana Belén, García-Pérez Angélica, Cobo Marién, Martín Francisco

Abstract excerpt

Administration of in vitro expanded mesenchymal stromal cells (MSCs) represents a promising therapy for regenerative medicine and autoimmunity. Both mouse and human MSCs ameliorate autoimmune disease in syn-, allo- and xenogeneic settings. However, MSC preparations are heterogeneous which impairs their therapeutic efficacy and endorses variability between experiments. This heterogeneity has also been a main...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipocytes
Share to Cell Differentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endoglin

Share to Immunomodulation

Share to Immunophenotyping

Share to Intracellular Signaling Peptides and Proteins

Share to Mesenchymal Stem Cells

Share to Osteocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 24124603
DOI: 10.1371/journal.pone.0076979
PMCID: PMC3790740

Genes

MSC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities.PMID 24124603Read ↗

Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and nichesSemantic proximity Read ↗

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.Semantic proximity Read ↗

Systematic Analysis of Reportedly Distinct Populations of Multipotent Bone Marrow-Derived Stem Cells Reveals a Lack of DistinctionSemantic proximity Read ↗

Functional heterogeneity of mesenchymal stem cells: Implications for cell therapySemantic proximity Read ↗

Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34posHematopoietic Stem Cell Propagation and Suppress Inflammatory ReactionSemantic proximity Read ↗

CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory PropertiesSemantic proximity Read ↗

Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biologySemantic proximity Read ↗

Phenotypic analysis and differentiation of murine mesenchymal stem cells.Semantic proximity Read ↗

Mesenchymal Stem Cell Population Derived from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic PropertiesSemantic proximity Read ↗

Isolation of human bone marrow mesenchymal stem cells using different membrane markers: comparison of colony/cloning efficiency, differentiation potential, and molecular profile.Semantic proximity Read ↗

Osteogenic Potential of Mouse Adipose-Derived Stem Cells Sorted for CD90 and CD105 In VitroSemantic proximity Read ↗

CD34 defines an osteoprogenitor cell population in mouse bone marrow stromal cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.